Latest news
IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update - PR NewswirePR Newswire · Tue, 04 Aug 2026 10:00:00 GMTIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PR NewswirePR Newswire · Fri, 31 Jul 2026 10:00:00 GMTIDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers - PR NewswirePR Newswire · Mon, 27 Jul 2026 10:00:00 GMT